BGBert Gold

Bert Gold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bert Gold has a total of 122 co-authors. Here are the top co-authors by number of shared publications:

  • Kate M. Im

    Center for Cancer Research, Cancer Inflammation Program, Human Genetics Section, National Cancer Institute – Frederick, Frederick, MD 21702, USA

    2 shared publications
  • Michael Dean

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA

    2 shared publications
  • Alfons Meindl

    Technical University Munich, Munich, Germany

    1 shared publication
  • Amanda Ewart Toland

    Department of Molecular Virology Immunology, and Medical Genetics and Internal Medicine, The Ohio State University, Columbus, USA

    1 shared publication
  • Ana Osorio

    Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    1 shared publication
  • Andrew Crenshaw

    Department of Genetics and of Medicine, Harvard Medical School, Boston, USA

    1 shared publication

Latest Publications

  • Association Assessment of Copy Number Polymorphism and Risk of Age-Related Macular Degeneration

    by Julie Sawitzke, Kate M. Im, Brittany Kostiha, Michael Dean, Bert Gold


  • Open Access

    Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

    by Kate M. Im, Hebon, Tomas Kirchhoff, Xianshu Wang, Todd Green, Clement Y. Chow, Joseph Vijai, Joshua Korn, Mia M. Gaudet, Zachary Fredericksen, et al.

    Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We studied the genotypes of hundreds of women from a large international consortium of BRCA1 and BRCA2 mutation carriers and found that AJ women exhibited long-range haplotypes compared to CNJ women. More than 50% of the AJ chromosomes with the BRCA1 185delAG mutation share an identical 2.1 Mb haplotype and nearly 16% of AJ chromosomes carrying the BRCA2 6174delT mutation share a 1.4 Mb haplotype. Simulations based on the best inference of Ashkenazi population demography indicate that long-range haplotypes are expected in the context of a genome-wide survey. Our results are consistent with the hypothesis that a local bottleneck effect from population size constriction events could by chance have resulted in the large haplotype blocks observed at high frequency in the BRCA1 and BRCA2 regions of Ashkenazi Jews.